Arne Scheu, CEO of LiliumX, is presenting at the 14th World Bispecific Summit

Boston, October 2, 2023 — Dr Arne Scheu, CEO of LiliumX, a pioneering biotechnology company specializing in advanced antibody design and discovery, is delighted to be speaking at the 14^th World Bispecific Summit held October 2-4, 2023 in Boston. He will showcase LiliumX's ground-breaking Universal Assembly Platform™ for rapid antibody engineering at the Novel Formats of Multispecifics Seminar.

The talk “Modular Discovery of Cis-Acting Bispecifics, Bispecific ADC & Multifunctional Drug Candidates” covers the potential of cis-acting drugs to provide novel mechanisms of action, describing LiliumX’s modular approach to drug candidate assembly, integrating adjacent fields of antibody modification. Herein, LiliumX will unveils its platform for discovery of bispecific antibody-drug conjugates (ADCs), combining multispecific, multivalency, and antibody-drug conjugation into a single drug discovery process.

LiliumX is excited to continue engaging with industry professionals and welcomes inquiries from those interested in learning more about their pioneering work.

For more information about the World Bispecific Summit, visit https://bispecific.com. For more information about LiliumX and their Universal Assembly Platform™, please visit www.liliumx.com or reach out at info@liliumx.com.

‍